Insights
Clients
Principal drugs of concern
AOD treatment
-
88% of all AOD treatment episodes were provided to people receiving treatment for their own drug use while a further 12% were for someone else’s AOD use
-
From 2015–16, the number of AOD treatment episodes rose by 18% from 206,395 in 2015–16 to 244,411 in 2024–25
-
In 2024–25, 3 in 5 (59%, 143,496) treatment episodes ended as an expected or planned completion and has remained similar since 2015–16
-
The median length of AOD treatment was four weeks for clients’ own AOD use and two weeks for clients who received support for someone else’s AOD use